Titan Pharmaceuticals TTNP
$ 3.35
2.45%
Quarterly report 2024-Q2
added 08-15-2024
Titan Pharmaceuticals EV/EBITDA Ratio 2011-2024 | TTNP
Annual EV/EBITDA Ratio Titan Pharmaceuticals
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
-0.717 | -0.762 | -0.301 | -1.19 | -1.97 | 14.8 | -9.83 | -9.53 | -60.7 | -14 | -7.42 |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
14.8 | -60.7 | -8.32 |